SenesTech Announced Results From A Pilot Of Evolve; Reports Over A 12-Month Period, Standardized Tracking-Tunnel Surveys Documented An 88% Reduction In Average Rat Activity Intensity And An 82% Reduction In The Proportion Of Monitoring Locations With Detectable Rat Activity
10/19/2026
Impact: 75
Basic Materials
SenesTech, Inc. (NASDAQ: SNES) reported significant results from a pilot program of its Evolve® Rat Birth Control™ in Chicago, showing an 88% reduction in average rat activity intensity and an 82% decrease in monitoring locations with detectable rat activity over a 12-month period. The company also announced preliminary record third-quarter 2026 revenue of approximately $1.1 million, marking a 40% sequential increase and a 55% year-over-year growth. Additionally, rodent-related 311 calls in the deployment area fell by 36%, while citywide calls increased by less than 1% during the same timeframe.
AI summary, not financial advice
Share: